Strict federal regulations and administrative obstacles have severely limited research with marijuana and its compounds. Several U.S. senators have reintroduced the Cannabidiol and Marijuana Research...
Read The ArticleAs part of the U.S. Department of Education’s (ED’s) effort to protect student privacy, it recently issued a comparison of the privacy provisions detailed in...
Read The ArticleClinical Monitoring Objectives Clinical trial management mandates procedural accuracy, careful planning, and coordinated execution. Sponsors and their monitors assess clinical studies to ensure alignment with...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleSeason 1 – Episode 26 – Academic Career Pathways (Part 1) For many graduate students, both academic and non-academic careers are possibilities, which can differ...
Read The ArticleThe U.S. Food and Drug Administration (FDA) proposed two new rules that would update regulations 21 CFR 50 (Protection of Human Subjects) and 21 CFR...
Read The ArticleOverview Have you heard about the Human Research Protection (HRP) club that is growing on the Clubhouse social audio app? If you’re curious, you can...
Read The ArticleCITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for...
Read The ArticleSeason 1 – Episode 25 – Title IX: Women in Athletics The Education Amendments of 1972 banned sex discrimination in federally funded educational programs and...
Read The ArticleThe HHS Office for Human Research Protections (OHRP) issued an updated guidance, titled Reporting Incidents to OHRP (2022) to replace 2011’s Guidance on Reporting Incidents to...
Read The Article
